The latest in funding & deals: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: VC funding deals: AblePay Health, Walapay, Frank, Welltory.
TRrexBio’s IPO Bags $116M to Bring the Immune System Back Into Balance
Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammation. Meanwhile, Retension Pharmaceuticals will use its IPO cash for mid-stage testing of a next-generation hypertension drug. The post TRrexBio’s IPO Bags $116M to Bring the Immune System Back Into Balance appeared fi…
Follow the full firehose on the HTC Wire, refreshed automatically every day.
Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.